Showing results (201-210 of 289) with videos related to

Sort By:
Pageof 29
Journal of Environmental Biology|September 6, 2011
Temporal variation of phytoplankton from the tropical reservoir Valle de Bravo, MexicoMartha Leticia Gaytan-Herrera, Víctor Martinez-Almeida, Maria Guadalupe Oliva-Martinez, et al.
Data in Brief|April 7, 2023
Petrophysical and petrothermal dataset of the sedimentary succession in the Oliana anticline (Southern Pyrenees)Pedro Ramirez-Perez, Irene Cantarero, Gabriel Cofrade, et al.
Circulation|January 26, 2018
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyJohn Simes, Kristy P Robledo, Harvey D White, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected]Stephen J Clarke, Sonia Yip, Chris Brown, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trialGary Wittert, Evan Atlantis, Carolyn Allan, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2014
Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adultsMary Waterhouse, Bich Tran, Bruce K Armstrong, et al.
Clinical Endocrinology|April 5, 2013
Predicting vitamin D deficiency in older Australian adultsBich Tran, Bruce K Armstrong, Kevin McGeechan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCTMark Ng Tang Fui, Rudolf Hoermann, Karen Bracken, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
BMC Cancer|August 20, 2021
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerAndrew Oar, Mark Lee, Hien Le, et al.
Pageof 29